BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10575919)

  • 21. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
    Baron F; Sadzot B; Wang F; Beguin Y
    Bone Marrow Transplant; 1998 Jul; 22(2):197-200. PubMed ID: 9707030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation for correction of severe aplastic anemia and primary immunodeficiency.
    Dupont B; Flomenberg N; O'Reilly RJ
    Ann Clin Res; 1981; 13(4-5):358-66. PubMed ID: 7039487
    [No Abstract]   [Full Text] [Related]  

  • 25. Pancreatitis following allogeneic bone marrow transplantation in a patient with aplastic anemia.
    Ikushima S; Hibi S; Todo S; Morimoto A; Sawada T; Tsunamoto K; Imashuku S
    Bone Marrow Transplant; 1996 Aug; 18(2):485-6. PubMed ID: 8864474
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis and treatment of aquired aplastic anemia].
    Kulagin AD; Lisukov IA; Kriuchkova IV; Sizikova SA; Gilevich AV; Denisova VV; Filimonov PN; Meniaeva EV; Pronkina NV; Kozhevnikov VS; Chernykh ER; Kozlov VA
    Ter Arkh; 2006; 78(11):48-54. PubMed ID: 17195527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoplastic/aplastic anemia. Role of bone marrow transplantation.
    Stewart FM
    Med Clin North Am; 1992 May; 76(3):683-97. PubMed ID: 1578964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin-inhibitor-induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia.
    Nishikawa T; Okamoto Y; Tanabe T; Shinkoda Y; Kodama Y; Tsuru Y; Kawano Y
    Pediatr Transplant; 2009 Aug; 13(5):641-4. PubMed ID: 18785910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance.
    Stachel D; Schmid I; Lang T; Haas RJ; Otté JB
    Transpl Int; 2002 Jan; 15(1):39-44. PubMed ID: 11875612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aplastic anemia. Alternative treatment by bone marrow transplantation].
    Fonseca T; Raposo J; Gomez B; d'Oliveira JJ; de Lacerda JM
    Acta Med Port; 1997 Jan; 10(1):99-102. PubMed ID: 9245186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Aplastic Anemia.
    Speck B; Nissen C; Tichelli A; Gratwohl A
    Oncologist; 1996; 1(6):367-370. PubMed ID: 10388018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
    Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
    Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation.
    Lee WY; Oh ES; Min CK; Kim DW; Lee JW; Kang MI; Min WS; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    Bone Marrow Transplant; 2001 Jul; 28(1):63-6. PubMed ID: 11498746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.
    Viollier R; Passweg J; Gregor M; Favre G; Kühne T; Nissen C; Gratwohl A; Tichelli A
    Ann Hematol; 2005 Jan; 84(1):47-55. PubMed ID: 15340760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome.
    Perkins JL; Neglia JP; Ramsay NK; Davies SM
    Bone Marrow Transplant; 2001 Sep; 28(5):523-6. PubMed ID: 11593328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
    Kanda Y; Usuki K; Inagaki M; Ohta A; Ogasawara Y; Obara N; Kako S; Kurokawa M; Shimada N; Suzuki T; Hama A; Yamaguchi H; Nakao S; Yamazaki H
    Int J Hematol; 2023 May; 117(5):660-668. PubMed ID: 36595144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
    Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.